S&P 500 health-care sector.
We resolve 95% of XLV’s reported NAV to covered tickers; the remaining ~5% is cash, non-equity, foreign lines and names we don’t cover — the honest tail of a CUSIP-based resolution, not a data gap you should read as holdings we hid.
Covered positions by weight, as of 2026-03-31. Each links to its stock page and our full verdict.
| # | Holding | Our call | % of NAV | Value |
|---|---|---|---|---|
| 1 | LLY | Buy | 13.74% | $5.30B |
| 2 | JNJ | Hold | 11.10% | $4.29B |
| 3 | ABBV | Hold | 7.25% | $2.80B |
| 4 | MRK | Hold | 5.63% | $2.17B |
| 5 | UNH | Sell | 4.62% | $1.78B |
| 6 | AMGN | Hold | 3.57% | $1.38B |
| 7 | TMO | Hold | 3.48% | $1.34B |
| 8 | ABT | Buy | 3.37% | $1.30B |
| 9 | GILD | Hold | 3.26% | $1.26B |
| 10 | ISRG | Hold | 3.09% | $1.19B |
| 11 | PFE | Hold | 3.01% | $1.16B |
| 12 | BMY | Hold | 2.33% | $899M |
| 13 | DHR | Hold | 2.25% | $868M |
| 14 | VRTX | Hold | 2.14% | $825M |
| 15 | SYK | Hold | 2.13% | $824M |
| 16 | BSX | Buy | 1.75% | $677M |
| 17 | CVS | Hold | 1.72% | $665M |
| 18 | REGN | Hold | 1.47% | $567M |
| 19 | HCA | Buy | 1.40% | $539M |
| 20 | CI | Buy | 1.32% | $511M |
| 21 | ELV | Hold | 1.22% | $470M |
| 22 | COR | Hold | 1.15% | $445M |
| 23 | ZTS | Buy | 0.94% | $363M |
| 24 | CAH | Hold | 0.94% | $362M |
| 25 | EW | Hold | 0.88% | $338M |
| 26 | IDXX | Hold | 0.85% | $326M |
| 27 | BDX | Hold | 0.84% | $326M |
| 28 | RMD | Buy | 0.62% | $238M |
| 29 | GEHC | Buy | 0.61% | $236M |
| 30 | A | Hold | 0.61% | $235M |
| 31 | WAT | Hold | 0.55% | $213M |
| 32 | IQV | Hold | 0.55% | $210M |
| 33 | BIIB | Hold | 0.51% | $196M |
| 34 | MTD | Hold | 0.48% | $187M |
| 35 | DXCM | Buy | 0.46% | $176M |
| 36 | LH | Hold | 0.42% | $161M |
| 37 | DGX | Hold | 0.41% | $157M |
| 38 | HUM | Hold | 0.39% | $152M |
| 39 | WST | Sell | 0.34% | $131M |
| 40 | ZBH | Hold | 0.34% | $130M |
| 41 | MRNA | Avoid | 0.33% | $129M |
| 42 | INCY | Hold | 0.30% | $114M |
| 43 | VTRS | Hold | 0.29% | $113M |
| 44 | CNC | Hold | 0.29% | $111M |
| 45 | COO | Hold | 0.26% | $102M |
| 46 | ALGN | Sell | 0.22% | $83.2M |
| 47 | RVTY | Hold | 0.19% | $72.3M |
| 48 | UHS | Buy | 0.19% | $71.9M |
| 49 | SOLV | Buy | 0.18% | $70.1M |
| 50 | BAX | Sell | 0.16% | $62.9M |
| 51 | CRL | Hold | 0.16% | $61.8M |
| 52 | TECH | Hold | 0.15% | $59.5M |
| 53 | HSIC | Hold | 0.14% | $53.7M |
Source: SEC Form N-PORT-P (the fund’s latest public fiscal-quarter-end report, filed ~2 months after the period). Weights and values are as reported in the filing — a delayed snapshot, not a live book. Positions are resolved to tickers via the filing’s identifiers and CUSIP mapping; unresolved lines are excluded. “Our call” is TENK/calls’s independent SEC-grounded verdict, not the fund’s view. No market-price data is used on this page.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.